Myriad Genetics, Inc. (MYGN) total debt

Total debt · fiscal 2025
$209.80M

Myriad Genetics, Inc. (MYGN) carried total debt of $209.80M at the end of fiscal 2025 (December 31, 2025). That is 49.5% higher than the $140.30M of fiscal 2024. Figures as of 18 Nov 2026, 10:53 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$209.80M
Change on fiscal 2024
+49.5%
Growth, 5 years
−1.3% a year
Highest on record
$233.50Mfiscal 2019
Lowest on record
$0.00fiscal 2021
Fiscal years on record
102017–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Myriad Genetics, Inc. total debt, in more detail

Over the five fiscal years to 2025 total debt shrank at a compound 1.3% a year. Across the 10 fiscal years on record (2017–2025), the highest was $233.50M in fiscal 2019 and the lowest $0.00 in fiscal 2021.

Total debt was 0.6× shareholders' equity at the end of fiscal 2025.

History · 10 fiscal years

Total debt by fiscal year

Myriad Genetics, Inc. total debt, year by year

Myriad Genetics, Inc. (MYGN) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$209.80M 49.5% up0.6×
2024$140.30M 7.8% down0.2×
2023$152.10M 4.9% up0.2×
2022$145.00M—0.2×
2021$0.00 100.0% down0.0×
2020$224.80M—0.3×
2020$224.40M 3.9% down0.2×
2019$233.50M 2,410.8% up0.2×
2018$9.30M 90.6% down0.0×
2017$99.10M—0.1×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on MYGN

Myriad Genetics, Inc., figure by figure

Myriad Genetics, Inc. (MYGN) overview: price, valuation and scorecard

Myriad Genetics, Inc. total debt: questions and answers

How much debt does Myriad Genetics, Inc. have?

Myriad Genetics, Inc. (MYGN) carried total debt of $209.80M at the end of fiscal 2025 (December 31, 2025). That is 49.5% higher than the $140.30M of fiscal 2024.

What is the growth rate of Myriad Genetics, Inc.'s total debt?

Over the five fiscal years to 2025 total debt shrank at a compound 1.3% a year.

What are the highest and lowest total debt figures on record for Myriad Genetics, Inc.?

Across the 10 fiscal years on record (2017–2025), the highest was $233.50M in fiscal 2019 and the lowest $0.00 in fiscal 2021.

How does Myriad Genetics, Inc.'s debt compare with its equity?

Total debt was 0.6× shareholders' equity at the end of fiscal 2025.

How is Myriad Genetics, Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Myriad Genetics, Inc. it is on record here for 10 fiscal years, 2017 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Myriad Genetics, Inc. (MYGN) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/MYGN/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.